Poznámky k epizodě
In this episode of The Macro Perspective, Marcos and Seamus cover Oral GLPs: why aren’t oral GLP-1 medications as popular as injectables? They cover bioavailability, stomach acid, liver effects, cost, and trial data showing more GI side effects with orals. They also cover the “pill burden” and the dosing rules for orals, like fasting and waiting 30 minutes. From there they move on to nasal peptides, insurance and microdosing, and a 36-week oral trial with 8–11% weight loss. They also discuss the generations of GLP-1 drugs, trials moving overseas, and future delivery options like patches and…

